Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma-Reference-Cited by-同舟云学术

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

Published:2014-03 Issue:3 Volume:83 Page:389-395
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kim Min Hwan,Shim Hyo Sup,Kang Dae Ryong,Jung Ji Ye,Lee Chang Young,Kim Dae Joon,Lee Jin Gu,Bae Mi Kyung,Kim Hye Ryun,Lim Sun Min,Kim Eun Young,Park Ji Soo,Chung Kyung Young,Kim Hyun-Jung,Kim Joo Hang,Cho Byoung Chul

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

3. A prospective phase II trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients (p) with mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR);Paz-Ares;J Clin Oncol,2006

4. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing;Imielinski;Cell,2012

5. New targetable oncogenes in non-small-cell lung cancer;Oxnard;J Clin Oncol,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC;The Oncologist;2024-02-24

2. Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma;Clinical and Translational Oncology;2023-02-05

3. Early-stage ALK-positive lung cancer: a narrative review;Translational Lung Cancer Research;2023-02

4. Validation and Modification of an Established Nomogram of Resected Non-Small Cell Lung Cancer Based on Genotypes;2023

5. Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials;International Journal of Molecular Sciences;2022-06-29